Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
Quark Pharmaceuticals Inc.
) Postpones IPO
6/29/2007 9:33:11 AM
NEW YORK, June 29 (Reuters) - Quark Pharmaceuticals Inc. postponed its initial public offering, which had been scheduled for June 27, due to concerns about "market conditions," underwriters said on Friday.
Announces CHF 32 Million Series A Funding
Koronis Pharmaceuticals, Inc.
Raises $20 Million Series D to Fund Phase 2 Proof-of-Concept Trials of HIV Therapeutic
ISTA Pharmaceuticals, Inc.
(ISTA) to Raise $36.75 Million through Private Financing
Secures $31 Million in Financing
Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics
Trends in Life Science Exits: How to Get Best Bang for Your Buck
Raises Euro 15 Million to Advance Oncology Pipeline
Raises SEK 27,7 Million to Fund Clinical Phase III Trial
(PKI) Establishes Wholly Owned Subsidiary in India
comments powered by Disqus.
comments powered by
Biotech/Pharma - IPO
Biotech/Pharma - Investor